| Project/Area Number |
16591884
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Pathobiological dentistry/Dental radiology
|
|---|
| Research Institution | Tokyo Medical and Dental University |
|---|
Principal Investigator |
HASHIGUCHI Masaaki Tokyo Medical and Dental University, Graduate School of Medical Science, Assistant Professor, 大学院・医歯学総合研究科, 助手 (20372443)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
AZUMA Miyuki Tokyo Medical and Dental University, Professor, 大学院・医歯学総合研究科, 教授 (90255654)
|
|---|
| Project Period (FY) |
2004 – 2005
|
| Project Status |
Completed (Fiscal Year 2005)
|
| Budget Amount *help |
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2005: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2004: ¥2,300,000 (Direct Cost: ¥2,300,000)
|
|---|
| Keywords | keratinocyte / co-signal molecule / mucosal immunity / 補助刺激分子 |
|---|
| Research Abstract |
Mucosal tissues including oral cavity are distinguished from the others in the point of immune responses. On the other hand, co-signal molecules are known to function positively or negatively. That is why these molecules are important for the regulation of immune responses. In this research, we aimed to control the unique immune responses of mucosa by a modulation of co-inhibitory molecules on keratinocytes, with a further desire of developing a mucosa vaccination system.
Genetically engineered animals are powerful tools for examine in vivo immune responses. We made a construct for the expression of a co-inhibitory molecule, B7-H1 (PD-L1) specifically on keratinocyte under the control of keratin 14 (K14) promoter and using this we established a K14-B7-H1 transgenic mouse. Keratinocytes from this transgenic mouse showed the higher level of B7-H1 but the other cells tested not. On the contact hypersensitivity model with painting DNFB on the belly and ears, K14-B7-H1 transgenic mice showed smaller swellings of ears when a relatively lower dose was administered and showed larger swellings when a relative higher dose was administered. As described previously, B7-H1 is known to be a co-inhibitory molecule. From this points, we had expected the smaller swellings despite of the dosages, but a higher dose induced larger swellings, which suggest that immune responses at mucosa are distinct where B7-H1 is involved. The further investigation is to be accomplished.
|
